Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CervoMed Inc. CRVO

Full chart Compare
Set alert

Price alert · CRVO

All alert types
1.56 USD +0.01 (+0.65%)

At closeNov 4, 2026, 4:00 PM EST

1.65 +0.09 +5.77%

After hours · Nov 4, 4:00 PM ET

1.46 Day range 1.68
1.46 52-week range 10.00
YTD
-80.25%
1 year
-77.78%

Financial health

Altman Z-Score

-4.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -2.7×
FY 2016: -1.3×FY 2017: -10.8×FY 2018: -0.4×FY 2019: -0.3×FY 2020: -2.7×FY 2021: -1.3×FY 2022: -0.7×FY 2023: -9.3×FY 2024: -1.2×FY 2025: -2.7×
FY 2016 5y median -1.3× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.9×
FY 2016: 2.5×FY 2017: 0.7×FY 2018: 0.4×FY 2019: 0.2×FY 2020: 1.7×FY 2021: 0.9×FY 2022: -0.4×FY 2023: 2.8×FY 2024: 0.5×FY 2025: 3.9×
FY 2016 5y median 0.9× FY 2025
P/FCF -3.0×
FY 2016: -2.1×FY 2017: -1.1×FY 2018: -0.6×FY 2019: -0.3×FY 2020: -3.2×FY 2021: -2.1×FY 2022: -1.5×FY 2023: -2.7×FY 2024: -1.1×FY 2025: -3.0×
FY 2016 5y median -2.1× FY 2025
EV/EBITDA -2.3×
FY 2016: -1.3×FY 2017: 11.2×FY 2018: 0.1×FY 2019: 1.0×FY 2020: -1.6×FY 2021: 0.4×FY 2022: -2.1×FY 2023: -5.8×FY 2024: -0.6×FY 2025: -2.3×
FY 2016 5y median -2.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -32.8%
FY 2016: -46.6%FY 2017: -87.0%FY 2018: -167.0%FY 2019: -319.6%FY 2020: -31.5%FY 2021: -47.9%FY 2022: -65.4%FY 2023: -36.7%FY 2024: -87.5%FY 2025: -32.8%
FY 2016 5y median -47.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -148.0%
FY 2016: -196.4%FY 2017: -6.4%FY 2018: -117.7%FY 2019: -58.6%FY 2020: -57.2%FY 2021: -69.0%FY 2022: 64.5%FY 2023: -29.4%FY 2024: -41.6%FY 2025: -148.0%
FY 2016 5y median -41.6% FY 2025
ROIC -151.0%
FY 2016: -97.7%FY 2017: -26.6%FY 2018: -67.5%FY 2019: -51.0%FY 2020: -56.2%FY 2021: -69.4%FY 2022: -101.7%FY 2023: -105.9%FY 2024: -46.5%FY 2025: -151.0%
FY 2016 5y median -101.7% FY 2025
ROA -115.2%
FY 2016: -103.2%FY 2017: -5.2%FY 2018: -100.9%FY 2019: -48.6%FY 2020: -51.2%FY 2021: -63.7%FY 2022: -139.6%FY 2023: -21.8%FY 2024: -37.8%FY 2025: -115.2%
FY 2016 5y median -63.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -55.2%
FY 2016: -132.2%FY 2017: 23.7%FY 2018: -6.0%FY 2019: 4.0%FY 2020: -38.3%FY 2021: -54.5%FY 2022: 85.9%FY 2023: -124.8%FY 2024: -133.3%FY 2025: -55.2%
FY 2016 FY 2025
EPS (diluted) -47.5%
FY 2016: 93.1%FY 2017: 93.9%FY 2018: -253.1%FY 2019: 68.9%FY 2020: 82.9%FY 2021: 17.7%FY 2022: 39.5%FY 2023: 92.7%FY 2024: -146.3%FY 2025: -47.5%
FY 2016 FY 2025
Free Cash Flow -41.9%
FY 2016: -106.1%FY 2017: -18.7%FY 2018: 15.7%FY 2019: 8.5%FY 2020: -37.5%FY 2021: -7.0%FY 2022: 82.3%FY 2023: -189.6%FY 2024: -121.9%FY 2025: -41.9%
FY 2016 FY 2025

Financial Health

Current Ratio 4.8×
FY 2016: 0.4×FY 2017: 3.6×FY 2018: 11.1×FY 2019: 8.5×FY 2020: 7.7×FY 2021: 12.9×FY 2022: 0.3×FY 2023: 3.8×FY 2024: 11.1×FY 2025: 4.8×
FY 2016 5y median 4.8× FY 2025
Quick Ratio 4.8×
FY 2016: 0.4×FY 2017: 3.6×FY 2018: 11.1×FY 2019: 8.5×FY 2020: 7.7×FY 2021: 12.9×FY 2022: 0.3×FY 2023: 3.8×FY 2024: 11.1×FY 2025: 4.8×
FY 2016 5y median 4.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.3×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -1.4×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: -0.0×FY 2017: -14.7×FY 2018: 0.4×FY 2019: 1.2×FY 2020: 1.2×FY 2021: 2.3×FY 2022: -1.4×FY 2023: 3.6×FY 2024: 0.6×FY 2025: 0.3×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: -501×FY 2017: -3.9×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -5921×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31